Diseases · Entity Annotation Prototype (beta)

2articles mentioning diseases

3disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: G/GEJ ×

G/GEJ

This disease is selected. Its supporting articles are shown below.

G/GEJ2

Articles mentioning G/GEJ

2 articles · page 1 of 1

CapeOX (capecitabine and oxaliplatin) combined with sintilimab and bevacizumab biosimilar (IBI305) for first-line treatment of advanced gastric or oesophagogastric junction adenocarcinoma: study protocol for a single-arm, phase Ib/II trial

bmjopen · abstract · 2026-01-09 · 2 matching annotations

80.5%

gastric or gastro-oesophageal junction (G/GEJ) cancer G/GEJ IBI305 sintilimab capecitabine CapeOX oxaliplatin bevacizumab chemotherapy

… been demonstrated to be effective as a first-line treatment of gastric or gastro-oesophageal junction (G/GEJ) cancer. The conventional treatment strategy for patients with advanced…

Single-arm, open-label, multicentre phase 1b/2 study to evaluate the safety and efficacy of fruquintinib combined with sintilimab and CAPEOX as a first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma (FUNCTION study): a study protocol

bmjopen · abstract · 2025-09-26 · 1 matching annotations

75.4%

G/GEJ Fruquintinib sintilimab CAPEOX oxaliplatin capecitabine chemotherapy immunotherapy